Manufacturing Chemist Stand Side with Syntegon

Published: 24-Jun-2024
Cell & Gene Therapy Contamination Control

Christian Lavarreda, Global Product Manager at Syntegon, speaks to Manufacturing Chemist

At ACHEMA 2024 in Frankfurt, Manufacturing Chemist spoke with Syntegon's Global Product Manager, Christian Lavarreda, to find out more about its novel modular bioprocessing platform, which can facilitate the simple and convenient routine maintenance and cleaning of a pharmaceutical cleanroom. 

Syntegon has also 'decluttered' the cleanroom space with its novel technology, as well as improving the ergonomics of the system.

Christian also explains the range of biopharmaceutical processes that can be facilitated by such a platform.

 

Manufacturing Chemist Stand Side...

"Manufacturing Chemist Stand Side" is a series of exclusive video interviews with leading companies in the pharmaceutical industry, conducted during key market events by our award-winning B2B team.

For more information on how you can be part of "Manufacturing Chemist Stand Side" contact Don Phares on +44 207 193 3219 or via email: don@hpcimedia.com.

 

 

  • Companies:
  • Syntegon Technology
See more

You may also like

Manufacturing

Veranova to expand US ADC and API capabilities with $30m investment

Read more
The extension of the Devens, Massachusetts site will allow Veranova to serve the growing demand of ADC manufacturing in the US

Trending Articles

  1. Veranova to expand US ADC and API capabilities with $30m investment The extension of the Devens, Massachusetts site will allow Veranova to serve the growing demand of ADC manufacturing in the US
  2. TekniPlex Healthcare expands Tyvek converting capabilities in EMEA region Added capability provides local sourcing and shorter lead times for customers throughout Europe, the Middle East and Africa
  3. GEA debuts novel kytero single-use perfusion separators The novel perfusion separators allows for continuous biopharmaceutical production without the need to wait for the batch run to finish before product extraction
  4. BIO debrief: the biotech innovation highlights Purolite’s Senior Global Director and Field Applications Scientist for Purification, Felix Solamo, discusses the highlights of the BIO 2024 trade show and where he thinks the industry is headed
  5. Sterling Pharma Solutions bolsters UK bioanalytical capabilities The expansion includes a novel laboratory space for the ADC analytical services team, which enhances the company's offering to those developing biologics

Upcoming event

CPhI South East Asia 2024

10-12 July 2024 | Exhibition and Conference | Bangkok, Thailand See all

You may also like

Manufacturing

Veranova to expand US ADC and API capabilities with $30m investment

The extension of the Devens, Massachusetts site will allow Veranova to serve the growing demand of ADC manufacturing in the US
Contamination Control

TekniPlex Healthcare expands Tyvek converting capabilities in EMEA region

Added capability provides local sourcing and shorter lead times for customers throughout Europe, the Middle East and Africa
Manufacturing

GEA debuts novel kytero single-use perfusion separators

The novel perfusion separators allows for continuous biopharmaceutical production without the need to wait for the batch run to finish before product extraction
Manufacturing

BIO debrief: the biotech innovation highlights

Purolite’s Senior Global Director and Field Applications Scientist for Purification, Felix Solamo, discusses the highlights of the BIO 2024 trade show and where he thinks the industry is headed
Research & Development

Antibody-drug conjugates are shaping the future of cancer treatments

Antibody-drug conjugates (ADCs) are skyrocketing in popularity for the treatment of various cancers, states a novel whitepaper from Novotech
Research & Development

PolTREG’s type-1 diabetes cell therapy demonstrates long-term safety and efficacy

The company’s lead asset PTG-007 exhibited a favourable safety and efficacy in paediatric patients over a 12 year period
Manufacturing

Abzena and Argonaut collaborate on end-to-end biopharma drug development initiative

The companies will integrate their capabilities to provide an end-to-end drug development programme for the biopharma industry, which is controlled by a single team for improved streamlining
Subscribe now